October 24, 2016 11:27 AM ET


Company Overview of Curemark, LLC

Company Overview

Curemark, LLC, a biopharmaceutical company, develops therapies for the treatment of neurological and other disorders. Its pipeline products include CM-AT, a treatment for autism; CM-4612 for the treatment of attention deficit hyperactivity disorder; CM-1212, a drug for the treatment of alcohol and drug addicted individuals; CM-PK, a compound for the treatment of Parkinson’s disease; and CM-182 for the treatment of schizophrenia. The company was founded in 2004 and is based in Rye, New York.

411 Theodore Fremd Avenue

Suite 206

Rye, NY 10580

United States

Founded in 2004





Key Executives for Curemark, LLC

Founder, Chief Executive Officer and Director
Vice President of Finance
Chief Operating Officer
Age: 43
Senior Vice President of Operations
Senior Scientist and Member of Scientific Advisory Board
Compensation as of Fiscal Year 2016.

Curemark, LLC Key Developments

Curemark, LLC Announces Blüm Study - A Phase 3 Clinical Trial for Children with Autism

Curemark, LLC announced that the Blüm Study, a Phase 3 clinical trial to evaluate the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now enrolling at 30 clinical sites across the United States. This 14-week, double-blind, randomized, placebo-controlled Phase 3 study is designed to determine if CM-AT may help improve core and non-core symptoms of Autism. CM-AT is designed to enhance protein digestion thereby potentially restoring the pool of essential amino acids. Essential amino acids play a critical role in the expression of several genes important to neurological function and serve as precursors to key neurotransmitters such as serotonin and dopamine.

Jzaneen Lalani Joins Curemark as Chief Operating Officer

Curemark announced the appointment of Jzaneen Lalani as Chief Operating Officer. Lalani brings more than 15 years of experience to her role as COO that spans operational areas, including M&A, human resources and corporate communications, in biotech and healthcare, with both private and publicly traded companies. Most recently, she was the Chief Corporate Counsel of HMS Holdings Corp. Before that she served as the General Counsel of Memory Pharmaceuticals Corp.

Curemark, LLC Presents at Rodman & Renshaw 17th Annual Global Investment Conference, Sep-10-2015 10:50 AM

Curemark, LLC Presents at Rodman & Renshaw 17th Annual Global Investment Conference, Sep-10-2015 10:50 AM. Venue: The St. Regis Hotel, Two East 55th Street, New York, NY 10022, United States.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Curemark, LLC, please visit curemark.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.